-
Highlights from the October 2023 Issue
October 2, 2023
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the October 2023 issue: Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in [...] -
Why Can’t We Flozinate? Reflections on Our Inability to Optimally Prescribe SGLT2 Inhibitors to the Patients That Need Them Most
September 20, 2023
Dr. James Torain is a second-year nephrology fellow at Duke University Hospital. He currently has an interest in implementation of home dialysis modalities. Health disparities have been a particular interest of his since completing his medical degree at Meharry Medical College. His fascination with the intricacies of renal physiology and CKD prevention developed during his residency at the University of Tennessee Health Science Center. Outside of medicine, Dr. Torain enjoys running, playing [...] -
“Honoring My Father’s Legacy”: An Interview
September 13, 2023
In A Few Words is a recurring AJKD feature that highlights the diverse stories that define kidney disease. In a recent piece, Dr Mohamed Hassanein reflected on his father’s influence that inspired him to become an international medical graduate in nephrology. AJKDBlog’s Interviews Editor, Timothy Yau @Maximal_Change, recently sat down with Dr Hassanein @kidneymo to discuss his father’s legacy. AJKD Interview – Dr. Hassanein, In A Few Words from Timothy Yau on Vimeo. If [...] -
Hyperkalemia and Potassium Binders: A Panel Discussion
September 7, 2023
In a recent Original Investigation published in AJKD, David Bushinsky and colleagues characterized the effect of patiromer on serum phosphorus in patients with CKD, hyperkalemia, and hyperphosphatemia. AJKD’s Social Media Editor, Timothy Yau @Maximal_Change recently sat down with his Rush Nephrology colleagues Pravir Baxi @Proximal_Baxi, Roger Rodby @NephRodby, and William Whittier @TWhittier_RUSH, for a deeper dive into hyperkalemia and potassium binders. If the embedded player above [...] -
Highlights from the September 2023 Issue
September 1, 2023
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the September 2023 issue: Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: [...]
NephMadness 2023
-
NephMadness
#NephMadness 2023: Heart Failure Devices Region
-
NephMadness
#NephMadness 2023: Transitions of Care Region
-
NephMadness
#NephMadness 2023: Onconephrology Region
-
NephMadness
#NephMadness 2023: Access to Kidney Transplantation Region
-
NephMadness
#NephMadness 2023: IgA Nephropathy Region
-
NephMadness
#NephMadness 2023: Mineralocorticoid Receptor Antagonists Region
-
NephMadness
#NephMadness 2023: Transgender Health Region
-
NephMadness
#NephMadness 2023: Thrombotic Microangiopathy Region
Atlas of Renal Pathology II
-
Atlas of Renal Pathology II
Recurrent and De Novo FSGS Following Kidney Transplantation
-
Atlas of Renal Pathology II
Atlas: Clinical Quiz 3
-
Atlas of Renal Pathology II
Acute and Chronic Antibody-Mediated Rejection Represent a Continuum of Endothelial Injury Involving Multiple Immune Mechanisms
-
Atlas of Renal Pathology II
AJKD Atlas of Renal Pathology: Cholesterol Emboli
-
Atlas of Renal Pathology II
Focal Segmental Glomerulosclerosis: An Approach to Pathologic Assessment
-
Atlas of Renal Pathology II
Practical Tips for the Diagnosis of Acute Antibody-Mediated Rejection
-
Atlas of Renal Pathology II
Atlas: Clinical Quiz 4
-
Atlas of Renal Pathology II
Diffuse Mesangial Sclerosis
-
Atlas of Renal Pathology II
Congenital Nephrotic Syndrome: Finnish Type or Diffuse Mesangial Sclerosis?
-
Atlas of Renal Pathology II
AJKD Atlas of Renal Pathology: Light Chain Cast Nephropathy
Follow Blog by Email:
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy